Breast Biopsy Devices Market (By Product: Biopsy Needles, Guidance Systems, Biopsy Tables, Localization Wires, Assay Kits, Liquid Biopsy Instruments, Others; By Guidance: Image-Guided Biopsy, Mammography-guided Stereotactic Biopsy, Ultrasound-guided Biopsy, MRI-guided Biopsy, Other Guidance Techniques, Liquid Biopsy, NGS-based Biopsy, PCR-based Biopsy, Microarray-based Biopsy; By Type) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2034
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Breast Biopsy Devices Market
5.1. COVID-19 Landscape: Breast Biopsy Devices Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Breast Biopsy Devices Market, By Product
8.1. Breast Biopsy Devices Market, by Product, 2023-2032
8.1.1 Biopsy Needles
8.1.1.1. Market Revenue and Forecast (2021-2032)
8.1.2. Guidance Systems
8.1.2.1. Market Revenue and Forecast (2021-2032)
8.1.3. Biopsy Tables
8.1.3.1. Market Revenue and Forecast (2021-2032)
8.1.4. Localization Wires
8.1.4.1. Market Revenue and Forecast (2021-2032)
8.1.5. Assay Kits
8.1.5.1. Market Revenue and Forecast (2021-2032)
8.1.6. Liquid Biopsy Instruments
8.1.6.1. Market Revenue and Forecast (2021-2032)
8.1.7. Others
8.1.7.1. Market Revenue and Forecast (2021-2032)
Chapter 9. Global Breast Biopsy Devices Market, By Guidance
9.1. Breast Biopsy Devices Market, by Guidance, 2023-2032
9.1.1. Image-Guided Biopsy
9.1.1.1. Market Revenue and Forecast (2021-2032)
9.1.2. Mammography-guided Stereotactic Biopsy
9.1.2.1. Market Revenue and Forecast (2021-2032)
9.1.3. Mammography-guided Stereotactic Biopsy
9.1.3.1. Market Revenue and Forecast (2021-2032)
9.1.4. MRI-guided Biopsy
9.1.4.1. Market Revenue and Forecast (2021-2032)
9.1.5. Other Guidance Techniques
9.1.5.1. Market Revenue and Forecast (2021-2032)
9.1.6. Liquid Biopsy
9.1.6.1. Market Revenue and Forecast (2021-2032)
9.1.7. NGS-based Biopsy
9.1.7.1. Market Revenue and Forecast (2021-2032)
9.1.8. PCR-based Biopsy
9.1.8.1. Market Revenue and Forecast (2021-2032)
9.1.9. Microarray-based Biopsy
9.1.9.1. Market Revenue and Forecast (2021-2032)
Chapter 10. Global Breast Biopsy Devices Market, By Type
10.1. Breast Biopsy Devices Market, by Type, 2023-2032
10.1.1. Needle Breast Biopsy
10.1.1.1. Market Revenue and Forecast (2021-2032)
10.1.2. Core Needle Biopsy (CNB)
10.1.2.1. Market Revenue and Forecast (2021-2032)
10.1.3. Fine Needle Aspiration Biopsy (FNAB)
10.1.3.1. Market Revenue and Forecast (2021-2032)
10.1.4. Vacuum-assisted Biopsy (VAB)
10.1.4.1. Market Revenue and Forecast (2021-2032)
10.1.5. Open Surgical Breast Biopsy
10.1.5.1. Market Revenue and Forecast (2021-2032)
10.1.6. Excisional
10.1.6.1. Market Revenue and Forecast (2021-2032)
10.1.7. Incisional
10.1.7.1. Market Revenue and Forecast (2021-2032)
10.1.8. Liquid Breast Biopsy
10.1.8.1. Market Revenue and Forecast (2021-2032)
10.1.9. Circulating Tumor Cells
10.1.9.1. Market Revenue and Forecast (2021-2032)
10.1.10. Circulating Tumor DNA (CtDNA)
10.1.10.1. Market Revenue and Forecast (2021-2032)
10.1.11. Other Biomarkers
10.1.11.1. Market Revenue and Forecast (2021-2032)
Chapter 11. Global Breast Biopsy Devices Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Product (2021-2032)
11.1.2. Market Revenue and Forecast, by Guidance (2021-2032)
11.1.3. Market Revenue and Forecast, by Type (2021-2032)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Product (2021-2032)
11.1.4.2. Market Revenue and Forecast, by Guidance (2021-2032)
11.1.4.3. Market Revenue and Forecast, by Type (2021-2032)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Product (2021-2032)
11.1.5.2. Market Revenue and Forecast, by Guidance (2021-2032)
11.1.5.3. Market Revenue and Forecast, by Type (2021-2032)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Product (2021-2032)
11.2.2. Market Revenue and Forecast, by Guidance (2021-2032)
11.2.3. Market Revenue and Forecast, by Type (2021-2032)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Product (2021-2032)
11.2.4.2. Market Revenue and Forecast, by Guidance (2021-2032)
11.2.4.3. Market Revenue and Forecast, by Type (2021-2032)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Product (2021-2032)
11.2.5.2. Market Revenue and Forecast, by Guidance (2021-2032)
11.2.5.3. Market Revenue and Forecast, by Type (2021-2032)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Product (2021-2032)
11.2.6.2. Market Revenue and Forecast, by Guidance (2021-2032)
11.2.6.3. Market Revenue and Forecast, by Type (2021-2032)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Product (2021-2032)
11.2.7.2. Market Revenue and Forecast, by Guidance (2021-2032)
11.2.7.3. Market Revenue and Forecast, by Type (2021-2032)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Product (2021-2032)
11.3.2. Market Revenue and Forecast, by Guidance (2021-2032)
11.3.3. Market Revenue and Forecast, by Type (2021-2032)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Product (2021-2032)
11.3.4.2. Market Revenue and Forecast, by Guidance (2021-2032)
11.3.4.3. Market Revenue and Forecast, by Type (2021-2032)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Product (2021-2032)
11.3.5.2. Market Revenue and Forecast, by Guidance (2021-2032)
11.3.5.3. Market Revenue and Forecast, by Type (2021-2032)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Product (2021-2032)
11.3.6.2. Market Revenue and Forecast, by Guidance (2021-2032)
11.3.6.3. Market Revenue and Forecast, by Type (2021-2032)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Product (2021-2032)
11.3.7.2. Market Revenue and Forecast, by Guidance (2021-2032)
11.3.7.3. Market Revenue and Forecast, by Type (2021-2032)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Product (2021-2032)
11.4.2. Market Revenue and Forecast, by Guidance (2021-2032)
11.4.3. Market Revenue and Forecast, by Type (2021-2032)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Product (2021-2032)
11.4.4.2. Market Revenue and Forecast, by Guidance (2021-2032)
11.4.4.3. Market Revenue and Forecast, by Type (2021-2032)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Product (2021-2032)
11.4.5.2. Market Revenue and Forecast, by Guidance (2021-2032)
11.4.5.3. Market Revenue and Forecast, by Type (2021-2032)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Product (2021-2032)
11.4.6.2. Market Revenue and Forecast, by Guidance (2021-2032)
11.4.6.3. Market Revenue and Forecast, by Type (2021-2032)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Product (2021-2032)
11.4.7.2. Market Revenue and Forecast, by Guidance (2021-2032)
11.4.7.3. Market Revenue and Forecast, by Type (2021-2032)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Product (2021-2032)
11.5.2. Market Revenue and Forecast, by Guidance (2021-2032)
11.5.3. Market Revenue and Forecast, by Type (2021-2032)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Product (2021-2032)
11.5.4.2. Market Revenue and Forecast, by Guidance (2021-2032)
11.5.4.3. Market Revenue and Forecast, by Type (2021-2032)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Product (2021-2032)
11.5.5.2. Market Revenue and Forecast, by Guidance (2021-2032)
11.5.5.3. Market Revenue and Forecast, by Type (2021-2032)
Chapter 12. Company Profiles
12.1. Cook Medical Incorporated
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Becton, Dickinson and Company
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Devicor Medical Products Inc.
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. C.R. Bard, Inc., Hologic Inc
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Argon Medical Devices
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Planmed OY
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Encapsule Medical Devices LLC
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Ethicon Endo-Surgery (Johnson and Johnson)
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client